LYNX CAPITAL GROUP LTD /ADV’s iShares US Medical Devices ETF IHI Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.02M	Buy	+55,994	New	+$2.74M	2.2%	11

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

LYNX CAPITAL GROUP LTD /ADV's IHI Position: Q4 2023 in Review

LYNX CAPITAL GROUP LTD /ADV opened a new position in iShares US Medical Devices ETF (IHI) in Q4 2023: 55,994 shares worth $3.02M. The stake represents 2.2% of the portfolio and ranks #11 among its holdings.

575 funds tracked by Wall St. Rank hold IHI as of Q4 2023.

LYNX CAPITAL GROUP LTD /ADV held 55,994 shares of iShares US Medical Devices ETF worth $3.02M as of Q4 2023.
iShares US Medical Devices ETF was a new LYNX CAPITAL GROUP LTD /ADV position in Q4 2023.
iShares US Medical Devices ETF made up 2.2% of LYNX CAPITAL GROUP LTD /ADV's portfolio in Q4 2023, its #11 holding.
575 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2023.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2023, filed 7 Aug 2026.